Papers
5
Total Citations
166
H-Index
3
About
Chunsen Wu is a clinical researcher whose work sits at the intersection of gynecologic oncology, surgical innovation, and health economics. His research has focused primarily on the adoption and evaluation of robotic minimally invasive surgery (MIS) for early-stage endometrial cancer, examining not only its clinical effectiveness but also its broader implications for patient safety and healthcare costs. Wu's most influential contributions emerged from his studies of Denmark's nationwide rollout of robotic surgery, demonstrating through large population-based cohort data that robotic MIS is associated with reduced severe complications compared to traditional abdominal hysterectomy — without compromising patient survival. His 2019 papers on complications and survival outcomes have garnered over 60 citations each, underscoring their significance to the surgical oncology community. Beyond clinical outcomes, Wu has critically interrogated the economic evidence base surrounding robotic surgery, authoring a widely cited systematic review revealing that costing methodology in the field is frequently of low quality — an important cautionary finding for health systems weighing substantial investments in robotic technology. Taken together, Wu's body of work provides valuable, evidence-driven guidance for clinicians, policymakers, and healthcare administrators navigating the complex adoption of advanced surgical technologies in gynecologic cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5